Peritoneal Dialysis: Case Forum

Honkanen E. , Tornroth T. , Gronhagen-Riska C. Natural history, clinical course and morphological evolution of membranous nephropathy. Nephrol Dial Transplant 1992; 7(Suppl 1): 35–41.

Schieppati A. , Mosconi L. , Perna A. Prognosis of untreated patients with idiopathic membranous nephropathy. N Engl J Med 1993; 329: 85–9.

Hunt L.P. Statistical aspects of survival in membranous nephropathy. Nephrol Dial Transplant 1992; 8(Suppl 1): 53–9.

Davidson A.M. , Cameron J.S. , Kerr D.N.S. The natural history of renal function in untreated membranous nephropathy. Clin Nephrol 1984; 22: 61–7.

Row R.G. , Cameron J.S. , Turner D.R. Membranous nephropathy -longterm follow up and association with neoplasia. Q J Med 1975; 174: 207–39.

Donadio J.V. , Torres V.E. , Velesa J.S. Idiopathic membranous nephropathy: the natural history of untreated patients. Kidney Int 1988; 33: 708–15.

Wehrmann M. , Bohle A. , Bogenschitz O. Long-term prognosis of chronic idiopathic membranous glomerulonephritis. An analysis of 334 cases with particular regard to tubulo interstitial changes. Clin Nephrol 1989; 31: 67–76.

Honkanen E. Survival in idiopathic membranous glomerulonephritis. Clin Nephrol 1986; 25: 122–8.

Ponticelli C. , Zucchelli P. , Passerini P. , Cesana B. Methylprednisolone plus chlorambucil as compared with methylprednisolone alone for the treatment of idiopathic membranous nephropathy. The Italian Idiopathic Membranous Nephropathy Treatment Study Group. N Engl J Med 1992; 327: 599–603.

Imperiale T.F. , Goldfarb S. , Berns J.S. Are cytotoxic agents beneficial in idiopathic membranous nephropathy? A meta-analysis of the controlled trials. J Am Soc Nephrol 1995; 5: 1553–8.

Couchoud C. , Laville M. , Boissel J.P. Treatment of membranous nephropathy: a meta-analysis (Editorial). Nephrol Dial Transplant 1994; 9: 469–70.

Dorhount Mees E.J. Fluid retention in renal disease: the genesis of renal oedema. In: Cameron S. , Davison A.M. , Grtinfeld J.P. , Kerr D. , Ritz E. , eds. Oxford textbook of clinical nephrology. Oxford: Oxford University Press, 1992: 262–75.

Ichikawa I. , Rennke H.G. , Hoyer J.R. Role of intra renal mechanisms in the impaired salt excretion of experimental nephrotic syndrome. J Clin Invest 1983; 71: 91–103.

Meyrier A. Treatment of nephrotic syndrome with cyclosporin A. What remains in 1994? Nephrol Dial Transplant 1994; 9: 596–8.

Velosa J.A. , Torres V.E. Benefits and risks of nonsteroidal antiinflammatory drugs in steroid-resistant nephrotic syndrome. Am J Kidney Dis 1986; 8: 345–50.

Fauchald P. , Noddeland H. , Norseth J. An evaluation of ultrafiltration as treatment of diuretic resistant oedema in nephrotic syndrome Acta Med Scand 1985; 217: 127–31.

Guyton A.C. , Taylor A.E. , Granger H.J. Dynamics and control of the body fluids. Philadelphia: Saunders, 1975.

Robson M. , Biro A. , Knobel B. Peritoneal dialysis in refractory congestive heart failure. Part II: Continuous ambulatory peritoneal dialysis. Perit Dial Bull 1983; 3: 133–4.

Prichard S.S. , Bargman J.M. The use of peritoneal dialysisin special situations. In: Gokal R. , Nolph K.D. , eds. The textbook of peritoneal dialysis. Dordrecht: Kluwer Academic Publishers, 1994: 751–68.

Gansevoort R.T. , Heeg J.E. , Vriesendorp R. Antiproteinuric drugs in patients with idiopathic membranous glomerulopathy NephrolDial Transplant 1992; 7(Suppl 1): 91–6.

Walser M. Is there necessity to limit protein intake? How do we prevent malnutrition? International Society of Nephrology, XIII International Congress of Nephrology, Abstract Themes, Madrid, Spain, 1995: 88.

Avram M.M. , Lipner H.I. , Gan A.C. Medical nephrectomy. The use of metallic salts for the control of massive proteinuria in the nephrotic syndrome. Trans Am Soc ArtifIntern Organs 1976; 22: 431–8.

Henrich W.L. , Goldman M. , Dotter C.T. Therapeutic renal arterial occlusion for elimination of proteinuria: ‘medical nephrectomy. Arch Intern Med 1976; 136: 840–2.

McCarron D.A. , Rubin R.J. , Barnes B.A. Therapeutic bilateral renal infarction in endstage renal disease. N Engl J Med 1976; 294: 652.

Baumelou A. , Legrain M. Medical nephrectomy with anti-inflammatory non-steroidal drugs. Br Med J 1982; 284: 234.

Torres V.E. , Velosa J.A. , Holley K.E. Meclofenamate treatment of recurrent idiopathic nephrotic syndrome with focal segmental glomerulosclerosis after renal transplantation. Mayo Clin Proc 1984; 59: 146–52.

Schreiner G.F. , Kees-Folts D. , Delmez J. Characterization of a macrophage (MqJ) specific lipid chemotactic factor (CF) in the urine and peritoneal dialysate of nephrotic patients with declining renal function. J Am Soc Nephrol 1992; 3: 419.

Kees-Folts D. , Sadow J.L. , Schreiner G.F. Tubular catabolism of albumin is associated with the release of inflammatory lipid. Kidney Int 1994; 45: 1697–709.